Guggenheim Maintains Buy on Adagene, Raises Price Target to $10

Benzinga Newsdesk www.benzinga.com Positive 59.3%

Neg 0% Neu 0% Pos 59.3%

Guggenheim analyst Paul Jeng maintains Adagene (NASDAQ:ADAG) with a Buy and raises the price target from $9 to $10.

Comments

No comments yet. Be the first!